In hospitalized COVID-19 patients, azvudine shows lower all-cause mortality and fewer adverse events than Paxlovid, with ...

TASS/. The Health Insurance Administration of South China's Hainan Province has temporarily included the country's oral anti-Covid drug Azvudine into the list of medicine covered by medical insurance.